ÂÜÀòÂÒÂ×

Kevin Blades is a Senior Research Scientist with extensive experience in developing new drugs for the treatment of gram negative bacteria. Kevin has worked at companies such as AMR Centre Ltd, Redx Pharma, and AstraZeneca. Kevin also has a background in organo fluorine chemistry, having obtained a Doctor of Philosophy degree from the University of Birmingham. Prior to their industry roles, Kevin served as a Post Doc at the University of Manchester where Kevin made significant contributions towards the development of new synthetic methodologies.